NuCana (NCNA) Exchange Rate Effect (2017 - 2025)
NuCana (NCNA) reported Exchange Rate Effect of $14631.8 for Q4 2025, down 98.24% on a YoY basis from $829142.2 in Q4 2024, and down 95.2% sequentially from $304955.8 in Q3 2025.
NuCana (NCNA) Exchange Rate Effect (2017 - 2025) Analysis & Trends
NuCana (NCNA) has 9 years of Exchange Rate Effect data on file, last reported at $14631.8 in Q4 2025.
- For the quarter ending Q4 2025, Exchange Rate Effect fell 98.24% year-over-year to $14631.8; the trailing twelve-month figure through Dec 2025 stood at $656295.1 (up 37.1% YoY), and the FY2025 full-year result was -$258428.0, down 153.34% from the prior year.
- Exchange Rate Effect eased to $14631.8 in Q4 2025, from $304955.8 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $3.9 million in Q2 2022 to a low of -$914224.5 in Q1 2021.
- A 5-year average of $338196.2 and a median of $16782.6 in 2024 frame the typical range for Exchange Rate Effect.
- Across the five-year window, Exchange Rate Effect plunged 218.96% in 2021 and soared 3081.93% in 2022, its largest moves.
- Tracing NCNA's Exchange Rate Effect over 5 years: stood at -$186025.5 in 2021, then soared by 2183.68% to $3.9 million in 2022, then sank by 116.36% to -$634228.6 in 2023, then surged by 230.73% to $829142.2 in 2024, then slumped by 98.24% to $14631.8 in 2025.
- Business Quant data shows NCNA's Exchange Rate Effect at $14631.8 in Q4 2025, $304955.8 in Q3 2025, and $829142.2 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | -7.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14,631.83 |
| Dec 31, 2025 | 14,631.83 |
| Sep 30, 2025 | 304,955.85 |
| Sep 30, 2025 | 304,955.85 |
| Dec 31, 2024 | 829,142.19 |
| Dec 31, 2024 | 829,142.19 |
| Sep 30, 2024 | -492,434.76 |
| Sep 30, 2024 | -492,434.76 |
| Jun 30, 2024 | 18,933.31 |
| Jun 30, 2024 | 18,933.31 |
| Mar 31, 2024 | 123,046.26 |
| Mar 31, 2024 | 123,046.26 |
| Dec 31, 2023 | -634,228.61 |
| Dec 31, 2023 | -634,228.61 |
| Sep 30, 2023 | 787,877.94 |
| Sep 30, 2023 | 787,877.94 |
| Jun 30, 2023 | -620,676.12 |
| Jun 30, 2023 | -620,676.12 |
| Mar 31, 2023 | -848,425.64 |
| Mar 31, 2023 | -848,425.64 |